C24:1 GD2 Ceramide (d18:1/24:1), synthetic A86163 (Previously 860163) C24:1 GD2 Ganglioside (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4Glcb-Ceramide(d18:1/24:1))
GD2 Ceramide is a promising target for cancer immunotherapy due to it being present in many tumor cells such as melanoma and neuroblastoma. Due to it being present in a wide variety of cancers, it is a promising tumor biomarker. By changing the chain length of the fatty acid portion of this ganglioside, it changes its membrane packing ability, signal transduction, and nanodomain formation.